Back to results
US 2026/0183302 A1Published application
Pdk1 regulatory compound and composition containing the same
AssigneeProvibio Co., Ltd.
InventorSeok Ju PARK
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeProvibio Co., Ltd.
InventorSeok Ju PARK
Estimating the term…
Provided is a 3-phosphoinositide-dependent protein kinase 1 (PDK1) modulator compound. The PDK1 modulator compound is provided as a compound represented by chemical formula 1, or a solvate, hydrate, prodrug, stereoisomer or pharmaceutically acceptable salt thereof, and regulates, inhibits or antagonizes the activity of PDK1, and thus can be used for anticancer, antifibrosis, anti-aging and reverse aging, or treatment or prevention of Alzheimer's disease or autoimmune disease. In addition, the present invention provides a composition for anticancer, antifibrosis, anti-aging and reverse aging, or treatment, prevention or alleviation of Alzheimer's disease or autoimmune disease, containing the PDK1 modulator compound and a salt thereof as active ingredients, and provides a method, in which the compound and a salt thereof are administered to a subject, for anticancer, antifibrosis, anti-aging and reverse aging, or treatment, prevention or alleviation of Alzheimer's disease or autoimmune disease.
A immunosuppressive compound characterized by comprising the compound represented by chemical formula 1 or its pharmaceutically acceptable salts:
Dependencies are inferred from the claim text.